106245-03-8 Usage
General Description
1-(2-(benzyloxy)-4-fluorophenyl)ethanone, also known as Fluorophenylbenzylketone, is a chemical compound with the molecular formula C16H13FO2. It is a ketone derivative with a benzyl group and a fluorophenyl group attached to the carbon chain. 1-(2-(benzyloxy)-4-fluorophenyl)ethanone is commonly used as a building block in the synthesis of various pharmaceuticals and other organic compounds. It is also utilized as a reagent in chemical reactions and as a starting material in the preparation of complex organic molecules. The presence of a fluorine atom in its chemical structure can affect its physical and chemical properties and make it useful in specific chemical reactions or applications.
Check Digit Verification of cas no
The CAS Registry Mumber 106245-03-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,2,4 and 5 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 106245-03:
(8*1)+(7*0)+(6*6)+(5*2)+(4*4)+(3*5)+(2*0)+(1*3)=88
88 % 10 = 8
So 106245-03-8 is a valid CAS Registry Number.
106245-03-8Relevant articles and documents
FLUOROPHENYL BETA-HYDROXYETHYLAMINES AND THEIR USE IN THE TREATMENT OF HYPERGLYCAEMIA
-
Page/Page column 65; 66, (2019/04/11)
There is herein provided a compound of formula (I).
Synthesis of fluorine-containing 3-hydroxyflavanones and isoflavones
Khlebnikova,Piven,Khripach,Lakhvich
experimental part, p. 33 - 37 (2011/07/30)
Fluorine-containing 3-hydroxyflavanones and isoflavones were synthesized by epoxidation of F-containing chalcones by hydrogen peroxide under basic conditions and subsequent intramolecular cyclization of the resulting epoxides using BF3·Et2O. The ratio of products depended on the presence and position of the F atom.
MODULATORS OF DOPAMINE NEUROTRANSMISSION
-
Page/Page column 55, (2009/12/05)
The present invention relates to novel 1-(2,3-dihydro-1,4-benzodioxin-2-yl)-methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically as dopaminergic stabilizers. In other aspects the invention relates to the use o